Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG2 | P78540 | 2/20 | 0.35 |
| ▸ | ARG1 | P05089 | 1/20 | 0.35 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22283924 | 0.83 | ALDH1A1 (0.37) | ARG2ARG1ALDH1A1TSHR | |
| SCHEMBL17141402 | 0.83 | ALDH1A1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL14739494 | 0.79 | ARG2 (0.45) | ARG2ARG1CAMK2A | |
| SCHEMBL810647 | 0.79 | TET2 (0.31) | — | |
| SCHEMBL7775190 | 0.77 | FFAR1 (0.46) | ARG2ARG1CAMK2AALDH1A1TSHR | |
| SCHEMBL18748755 | 0.77 | FFAR1 (0.46) | ARG2ARG1CAMK2AALDH1A1TSHR | |
| SCHEMBL5163591 | 0.73 | ARG2 (0.35) | ARG2ARG1CAMK2AALDH1A1TSHR | |
| SCHEMBL2374038 | 0.73 | ARG2 (0.35) | ARG2ARG1CAMK2AALDH1A1TSHR | |
| SCHEMBL723172 | 0.72 | ALDH1A1 (0.35) | ARG2ARG1ALDH1A1TSHRTP53 | |
| SCHEMBL4810549 | 0.71 | LMNA (0.47) | CAMK2AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3918017-A1 | BINDER FOR AN AQUEOUS COATING COMPOSITION | Allnex Austria GmbH (AT) | 2021-12-08 | — | — | EP | disclosed |
| EP-3712190-A1 | BINDER FOR AN AQUEOUS COATING COMPOSITION | ALLNEX AUSTRIA GmbH (AT) | 2020-09-23 | — | — | EP | disclosed |
| WO-2020157228-A1 | BINDER FOR AN AQUEOUS COATING COMPOSITION | ALLNEX AUSTRIA GMBH (AT) | 2020-08-06 | — | — | WO | disclosed |
| EP-3689986-A1 | BINDER FOR AQUEOUS COATING COMPOSITIONS | ALLNEX AUSTRIA GmbH (AT) | 2020-08-05 | — | — | EP | disclosed |
| US-20110251158-A1 | FULLERENE THERAPIES FOR INFLAMMATION AND INHIBITION OF BUILD-UP OF ARTERIAL PLAQUE | LUNA INNOVATIONS INCORPORATED (US) | 2011-10-13 | — | — | US | disclosed |
| US-5280072-A | Solid pulverulent form | BAYER AKTIENGESELLSCHAFT (DE) | 1994-01-18 | — | — | US | disclosed |
| EP-0441527-A2 | Stabilized polymer latex composition | ICI AMERICAS INC. (US) | 1991-08-14 | — | — | EP | disclosed |
| US-5011883-A | Containing protective colloid and alkyd resin | ICI AMERICAS INC. (US) | 1991-04-30 | — | — | US | disclosed |
| US-4983491-A | LITHOGRAPHIC PRINTING PLATES | FUJI PHOTO FILM CO., LTD. | 1991-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251158-A1 | FULLERENE THERAPIES FOR INFLAMMATION AND INHIBITION OF BUILD-UP OF ARTERIAL PLAQUE | IL1B, IL1A, CD68 | ARG2 153/4885ARG1 96/4885CAMK2A 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.